OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 87 citing articles:

An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1141-1160
Open Access | Times Cited: 508

Bile acids and their receptors in metabolic disorders
Stefano Fiorucci, Eleonora Distrutti, Adriana Carino, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101094-101094
Closed Access | Times Cited: 174

Hepatic macrophages: Key players in the development and progression of liver fibrosis
Da Cheng, Jin Chai, Huiwen Wang, et al.
Liver International (2021) Vol. 41, Iss. 10, pp. 2279-2294
Open Access | Times Cited: 130

Functional roles of sphingolipids in immunity and their implication in disease
Mingyu Lee, Suh Yeon Lee, Yoe‐Sik Bae
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 6, pp. 1110-1130
Open Access | Times Cited: 65

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Lei Su, Yunhuan Gao, Rongcun Yang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 48

Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
Vlad Țâru, Gyöngyi Szabó, Wajahat Z. Mehal, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. 895-910
Open Access | Times Cited: 32

Immunomodulation of wound healing leading to efferocytosis
Yun Zhao, Minxiong Li, Jiayi Mao, et al.
Smart Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 20

Bile acids as inflammatory mediators and modulators of intestinal permeability
Nathan Calzadilla, Shane M. Comiskey, Pradeep K. Dudeja, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50

Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
Hongyu Chen, Junmin Wang, Caiyun Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113341-113341
Open Access | Times Cited: 45

Nanotechnology in Drug Delivery for Liver Fibrosis
Lihong Gu, Feng Zhang, Jinhui Wu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 38

Endoplasmic Reticulum Stress and Mitochondrial Stress in Drug-Induced Liver Injury
Sisi Pu, Yangyang Pan, Qian Zhang, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3160-3160
Open Access | Times Cited: 27

Immunology of bile acids regulated receptors
Stefano Fiorucci, Silvia Marchianò, Ginevra Urbani, et al.
Progress in Lipid Research (2024) Vol. 95, pp. 101291-101291
Closed Access | Times Cited: 13

Sphingosine 1-Phosphate Regulates Obesity and Glucose Homeostasis
Kazuo Kajita, Isao Ishii, Ichiro Mori, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 932-932
Open Access | Times Cited: 9

Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy
Hiroyuki Nojima, Hiroaki Shimizu, Takashi Murakami, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 850-850
Open Access | Times Cited: 8

Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy
Naths Grazia Sukubo, Paolo Bigini, Annalisa Morelli
Beilstein Journal of Nanotechnology (2025) Vol. 16, pp. 97-118
Open Access | Times Cited: 1

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Yulin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 37

Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis
Benedikt Kaufmann, Lin Kui, Agustina Reca, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 14, Iss. 4, pp. 751-767
Open Access | Times Cited: 32

Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA/S1PR2/ZBP1/p-MLKL axis
Yang Shen, Na Chang, Weiyang Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 20

Sphingosine 1-phosphate signaling during infection and immunity
Sabira Mohammed, A. R. Bindu, Viswanathan Arun, et al.
Progress in Lipid Research (2023) Vol. 92, pp. 101251-101251
Closed Access | Times Cited: 19

Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling
Huiling Cao, Lin Chen, Ziyang Zeng, et al.
PeerJ (2024) Vol. 12, pp. e16744-e16744
Open Access | Times Cited: 6

Lipid regulation of NLRP3 inflammasome activity through organelle stress
J. Liang, Iain D. C. Fraser, Clare Bryant
Trends in Immunology (2021) Vol. 42, Iss. 9, pp. 807-823
Open Access | Times Cited: 37

Bile acid receptors and signaling crosstalk in the liver, gut and brain
Jessica M. Ferrell, John Y.L. Chiang
Liver Research (2021) Vol. 5, Iss. 3, pp. 105-118
Open Access | Times Cited: 34

Page 1 - Next Page

Scroll to top